Two-year follow-up of a patient with successful continuation of clozapine treatment despite morning pseudoneutropenia.
Esposito
David
D
Aouillé
Jérémie
J
Rouillon
Frédéric
F
Limosin
Frédéric
F
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002940:Circadian Rhythm; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000139:chemically induced*; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003024:Clozapine